Biotech industry’s still waiting to break out

Biotech industry’s still waiting to break out
It turns out that even with the genome in hand, discovering drugs and testing them to prove they work is an expensive, grueling process.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!